Novelix Pharmaceuticals Ltd
NSE: BSE: 536565
₹55.95
(1.18%)
Fri, 08 May 2026, 04:39 pm
Market Cap978.16M
PE Ratio45.95
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KNovelix Pharmaceuticals Income Statement
| Particulars | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 272.74M | 316.16M | 68.48M | 165.19M | 110.85M | 58.69M | 57.39M | 63.46M | 57.13M | 91.84M | 104.96M | 98.85M | 102.44M | 92.42M | 8.43M | 14.05M | 42.24M | 307.18M |
| Gross profit | 640.00K | 276.45M | 32.99M | 7.70M | 1.82M | 7.75M | 8.61M | 9.51M | 6.02M | 5.63M | 6.57M | -1.85M | 1.26M | -2.95M | -1.78M | -1.70M | 2.18M | 10.30M |
| Operating expenses (excl. COGS) | 0 | -276.24M | -28.80M | -6.39M | -3.07M | -2.99M | -2.60M | -4.68M | -3.99M | -4.44M | -8.68M | -7.47M | -8.15M | -37.12M | -1.66M | -4.04M | -5.04M | -9.09M |
| Selling/general/admin expenses, total | — | -276.16M | -28.77M | -6.33M | -3.01M | -2.88M | -2.48M | -4.48M | -3.88M | -4.40M | -8.51M | -7.42M | -8.04M | -36.83M | -1.65M | -4.04M | -4.30M | -9.10M |
| Research & development | — | — | — | — | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | 0 | — |
| Selling/general/admin expenses, other | — | -276.16M | -28.77M | -6.33M | -3.01M | -2.88M | -2.48M | -4.48M | -3.88M | -4.40M | -8.51M | -7.42M | -8.04M | -36.83M | -1.65M | -4.04M | -4.30M | -9.10M |
| Other operating expenses, total | 0 | -77.99K | -33.55K | -52.04K | -63.62K | -112.07K | -119.73K | -200.44K | -107.60K | -40.40K | -169.09K | -54.48K | -104.19K | -288.34K | -11.45K | -6.00K | -741.01K | 10.43K |
| Operating income | 640.00K | 505.65K | 4.19M | 880.14K | -1.25M | 4.76M | 6.01M | 4.83M | 2.03M | 1.19M | -2.10M | -9.32M | -6.89M | -40.06M | -3.44M | -5.74M | -2.86M | 1.21M |
| Non-operating income, total | 5.70M | 4.09M | 4.89M | 6.07M | 7.30M | 715.04K | 88.16K | -2.11M | 386.94K | 744.18K | 26.09K | 8.08M | 4.74M | 2.80M | -12.21M | 5.15M | 3.07M | 23.10K |
| Interest expense, net of interest capitalized | 0 | -115.96K | -5.49K | -133.57K | -85.41K | -70.36K | -77.09K | -50.99K | -18.66K | -506.13K | -1.61M | -1.31M | -1.19M | -644.80K | -1.17K | -2.70K | -2.70K | -6.45K |
| Interest capitalized | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 5.70M | 4.21M | 4.90M | 6.20M | 7.39M | 785.39K | 165.25K | 23.93K | 1.34M | 1.25M | 1.75M | 9.39M | 5.93M | 3.44M | -12.21M | 5.16M | 3.07M | 29.55K |
| Non-operating interest income | — | 4.30M | 4.26M | 5.14M | 5.96M | 0 | 0 | 0 | 0 | 344.60K | 81.27K | 5.78M | 4.61M | 3.34M | 2.98M | 2.73M | 2.02M | 149.15K |
| Miscellaneous non-operating expense | 5.70M | -89.36K | 641.71K | 1.06M | 1.42M | 785.39K | 165.25K | 23.93K | 1.34M | 905.72K | 1.67M | 3.61M | 1.32M | 102.92K | -15.19M | 2.43M | 1.06M | -119.60K |
| Unusual income/expense | — | — | — | — | — | — | — | -2.09M | -932.31K | — | -114.17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 6.33M | 4.60M | 9.08M | 6.95M | 6.05M | 5.47M | 6.09M | 2.71M | 2.42M | 1.94M | -2.08M | -1.24M | -2.15M | -37.27M | -15.66M | -584.76K | 212.57K | 1.23M |
| Taxes | -1.43M | -1.32M | -2.19M | -2.23M | -1.41M | -1.70M | -1.94M | -1.29M | -1.12M | -1.60M | -1.41M | -238.45K | -441.25K | -137.75K | 54.72K | -14.54K | -108.45K | -388.23K |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -566.67K | -304.32K | -443.85K | -416.98K | -940.36K | -242.67K | 242.49K | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | — | — | 0 | 0 | 0 | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 4.91M | 3.28M | 6.90M | 4.72M | 4.64M | 3.77M | 4.16M | 851.40K | 991.20K | -109.78K | -3.90M | -2.42M | -2.83M | -37.39M | -15.60M | -599.30K | 104.12K | 845.20K |
| Net income | 4.91M | 3.28M | 6.90M | 4.72M | 4.64M | 3.77M | 4.16M | 851.40K | 991.20K | -109.78K | -3.90M | -2.42M | -2.83M | -37.39M | -15.60M | -599.30K | 104.12K | 845.20K |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 4.91M | 3.28M | 6.90M | 4.72M | 4.64M | 3.77M | 4.16M | 851.40K | 991.20K | -109.78K | -3.90M | -2.42M | -2.83M | -37.39M | -15.60M | -599.30K | 104.12K | 845.20K |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 2.93M | 2.49M | 6.56M | 3.92M | 1.37M | 7.42M | 8.86M | 8.92M | 5.54M | 3.10M | 267.70K | -7.20M | -4.97M | -37.98M | -2.73M | -5.18M | -2.48M | 1.59M |
| EBIT | 640.00K | 209.13K | 4.19M | 1.31M | -1.25M | 4.76M | 6.01M | 4.83M | 2.03M | 1.19M | -2.10M | -9.32M | -6.89M | -40.06M | -3.44M | -5.74M | -2.86M | 1.21M |
| Total operating expenses | -272.10M | -315.95M | -64.29M | -163.88M | -112.10M | -53.93M | -51.39M | -58.63M | -55.10M | -90.65M | -107.06M | -108.17M | -109.33M | -132.48M | -11.88M | -19.79M | -45.10M | -305.97M |
| Prepaid expenses | — | 1.01M | 997.69K | 1.96M | 1.58M | 1.32M | 1.56M | 2.10M | 1.24M | 1.34M | 29.41K | 21.03K | 55.16K | 23.17K | 28.26K | 130.25K | 8.48K | 175.00K |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital and operating lease obligations | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | 1.93M | 2.06M | 2.06M | 1.63M | 1.37M | 1.16M | 831.83K | 238.31K | 706.46K | 835.01K | 22.54K | 190.25K | 328.00K | — | — | — | — |
| Deferred income, non-current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 2.05M | 2.75M | 5.07M | 3.65M | 4.06M | 5.00M | 5.25M | 5.01M | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | — | 0 | 0 | 0 | 0 | -2.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800